GlobalData's clinical trial report, "Adenomas Global Clinical Trials Review, H1, 2012" provides data on the Adenomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Adenomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Adenomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Adenomas Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Adenomas , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Adenomas
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Adenomas
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Adenomas Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Agouron Pharmaceuticals Inc.
Clinical Trial Overview of Agouron Pharmaceuticals Inc.
Nihon Pharmaceutical Industry Co., Ltd.
Clinical Trial Overview of Nihon Pharmaceutical Industry Co., Ltd.
BTG plc
Clinical Trial Overview of BTG plc
ArQule, Inc.
Clinical Trial Overview of ArQule, Inc.
Bayer AG
Clinical Trial Overview of Bayer AG
ImClone LLC
Clinical Trial Overview of ImClone LLC
Novartis AG
Clinical Trial Overview of Novartis AG
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Fourth Military Medical University
Clinical Trial Overview of Fourth Military Medical University
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Mid-Atlantic Oncology Program
Clinical Trial Overview of Mid-Atlantic Oncology Program
Stanford University
Clinical Trial Overview of Stanford University
H. Lee Moffitt Cancer Center & Research Institute
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
University of California, Irvine
Clinical Trial Overview of University of California, Irvine
National Taiwan University Hospital
Clinical Trial Overview of National Taiwan University Hospital
Vanderbilt-Ingram Cancer Center
Clinical Trial Overview of Vanderbilt-Ingram Cancer Center
Dartmouth-Hitchcock Medical Center
Clinical Trial Overview of Dartmouth-Hitchcock Medical Center
Cancer Prevention Institute of California
Clinical Trial Overview of Cancer Prevention Institute of California
Huashan Hospital
Clinical Trial Overview of Huashan Hospital
University of Pittsburgh
Clinical Trial Overview of University of Pittsburgh
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Clinical Trial Overview of Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Nantes University Hospital
Clinical Trial Overview of Nantes University Hospital
Universitaire Ziekenhuizen Leuven
Clinical Trial Overview of Universitaire Ziekenhuizen Leuven
Federal University of Sao Paulo
Clinical Trial Overview of Federal University of Sao Paulo
Cedars-Sinai Medical Center
Clinical Trial Overview of Cedars-Sinai Medical Center
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
List of Tables
Adenomas Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Adenomas Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Adenomas Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Adenomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Adenomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Adenomas Therapeutics Clinical Trials, North America, Top Countries, 2012*
Adenomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012*
Adenomas Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012*
Adenomas Global Clinical Trials Review, H1, 2012 published by GlobalData in May 21, 2012. This report consists of Pages: 99 and the price starts from US $ 1000.
The contents of this page may be different from the latest version. Please contact us for details.
